Webster S, Les S, Deleon N, Heck D, Tsuj N, Clemente M
Immun Ageing. 2025; 22(1):9.
PMID: 39994686
PMC: 11849284.
DOI: 10.1186/s12979-025-00502-2.
Sturzbecher L, Bartolomaeus H, Bartolomaeus T, Bolz S, Sekulic A, Ueffing M
Front Immunol. 2025; 16:1520188.
PMID: 39975545
PMC: 11835843.
DOI: 10.3389/fimmu.2025.1520188.
Harju N, Kauppinen A, Loukovaara S
Int J Mol Sci. 2025; 26(3).
PMID: 39940795
PMC: 11817287.
DOI: 10.3390/ijms26031025.
Sturzbecher L, Strauss O
Adv Exp Med Biol. 2025; 1468:3-7.
PMID: 39930164
DOI: 10.1007/978-3-031-76550-6_1.
Koller A, Preishuber-Pflugl J, Mayr D, Brunner S, Ladek A, Runge C
Aging (Albany NY). 2025; 17(2):308-328.
PMID: 39891615
PMC: 11892928.
DOI: 10.18632/aging.206193.
Photoreceptor metabolic window unveils eye-body interactions.
Yang S, Xin Z, Cheng W, Zhong P, Liu R, Zhu Z
Nat Commun. 2025; 16(1):697.
PMID: 39814712
PMC: 11736035.
DOI: 10.1038/s41467-024-55035-x.
A Better Understanding of the Clinical and Pathological Changes in Viral Retinitis: Steps to Improve Visual Outcomes.
Nguyen N, Conrady C
Microorganisms. 2025; 12(12.
PMID: 39770716
PMC: 11678148.
DOI: 10.3390/microorganisms12122513.
Prospects of anti-GD2 immunotherapy for retinoblastoma.
Zhang X, You W, Wang Y, Dejenie R, Wang C, Huang Y
Front Immunol. 2024; 15:1499700.
PMID: 39620227
PMC: 11604707.
DOI: 10.3389/fimmu.2024.1499700.
Ocular immune-related diseases: molecular mechanisms and therapy.
Wang Y, Gao S, Cao F, Yang H, Lei F, Hou S
MedComm (2020). 2024; 5(12):e70021.
PMID: 39611043
PMC: 11604294.
DOI: 10.1002/mco2.70021.
Inhibiting NLRP3 Inflammasome Activation to Alleviate Retinal Inflammation and Protect the Optic Nerve of OPTN(E50K)Mice.
Wang S, Xiao R, Lu Y, Zhang Y, Zhang S, Liu X
Inflammation. 2024; .
PMID: 39578308
DOI: 10.1007/s10753-024-02178-0.
Oxidative Stress and Inflammation-Related mRNAs Are Elevated in Serum of a Finnish Wet AMD Cohort.
Liukkonen M, Helotera H, Siintamo L, Ghimire B, Mattila P, Kivinen N
Invest Ophthalmol Vis Sci. 2024; 65(13):30.
PMID: 39546296
PMC: 11578155.
DOI: 10.1167/iovs.65.13.30.
The Role of Immune Cells and Signaling Pathways in Diabetic Eye Disease: A Comprehensive Review.
Barone V, Surico P, Cutrupi F, Mori T, Gallo Afflitto G, Di Zazzo A
Biomedicines. 2024; 12(10).
PMID: 39457658
PMC: 11505591.
DOI: 10.3390/biomedicines12102346.
Genetic liability to higher frailty index may increase the risk of ophthalmic disease.
Lin J, Lin L
Int Ophthalmol. 2024; 44(1):397.
PMID: 39347840
DOI: 10.1007/s10792-024-03319-y.
NLRP3 and autophagy in retinal ganglion cell inflammation in age-related macular degeneration: potential therapeutic implications.
Wang X, Gao Y, Yuan Q, Zhang M
Int J Ophthalmol. 2024; 17(8):1531-1544.
PMID: 39156786
PMC: 11286452.
DOI: 10.18240/ijo.2024.08.20.
Identification of the Metabolic Signature of Aging Retina.
Mu W, Han X, Tong M, Ben S, Yao M, Zhao Y
Transl Vis Sci Technol. 2024; 13(8):8.
PMID: 39102240
PMC: 11309042.
DOI: 10.1167/tvst.13.8.8.
Protective effects of CY-09 and astaxanthin on NaIO-induced photoreceptor inflammation the NLRP3/autophagy pathway.
Wang X, Gao Y, Yuan Q, Zhang M
Int J Ophthalmol. 2024; 17(7):1217-1231.
PMID: 39026909
PMC: 11246927.
DOI: 10.18240/ijo.2024.07.05.
Aryl hydrocarbon receptor (AhR)-mediated immune responses to degeneration of the retinal pigment epithelium.
Karmoker J, Bounds S, Cai J
Biochim Biophys Acta Mol Basis Dis. 2024; 1870(7):167351.
PMID: 39004382
PMC: 11330344.
DOI: 10.1016/j.bbadis.2024.167351.
Grand Challenges in Ocular Inflammatory Diseases.
Xu H, Rao N
Front Ophthalmol (Lausanne). 2024; 2:756689.
PMID: 38983535
PMC: 11182270.
DOI: 10.3389/fopht.2022.756689.
SPI1-mediated macrophage polarization aggravates age-related macular degeneration.
Qi S, Zhang Y, Kong L, Bi D, Kong H, Zhang S
Front Immunol. 2024; 15:1421012.
PMID: 38979414
PMC: 11228255.
DOI: 10.3389/fimmu.2024.1421012.
The Complement System as a Therapeutic Target in Retinal Disease.
Ong J, Zarnegar A, Selvam A, Driban M, Chhablani J
Medicina (Kaunas). 2024; 60(6).
PMID: 38929562
PMC: 11205777.
DOI: 10.3390/medicina60060945.